Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Tumor Immunotherapy01:27

Tumor Immunotherapy

864
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
864
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

8.1K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
8.1K
Combination Therapies and Personalized Medicine02:50

Combination Therapies and Personalized Medicine

5.6K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
5.6K
Cancer Therapies02:49

Cancer Therapies

9.1K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
9.1K
Cancer Vaccines01:30

Cancer Vaccines

626
Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
626

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Comparative efficacy and economic impact of sequential triple therapy versus nano-silver dressings in delayed-presentation low-temperature burns: A retrospective cohort study.

Burns : journal of the International Society for Burn Injuries·2026
Same author

Niraparib in pancreatic cancer with germline or somatic DNA damage repair (DDR) gene alterations (BRCA and beyond): A phase II study (NIRA-PANC).

The oncologist·2026
Same author

Perioperative therapy for resectable and borderline resectable pancreatic adenocarcinoma: an Academic Gastrointestinal Cancer Consortium Study.

The oncologist·2025
Same author

Clinical Efficacy of Different Epidermal Dressings in Patients with Second Degree Burns: A Systematic Review and Bayesian Network Meta-Analysis.

The international journal of lower extremity wounds·2025
Same author

Cytomegalovirus hepatitis after treatment with dostarlimab for colorectal cancer.

BMJ case reports·2025
Same author

Effects of traditional fitness qigong exercise on frailty status and overall well-being in frail or pre-frail patients: a systematic review and meta-analysis.

Frontiers in medicine·2025

Related Experiment Video

Updated: Nov 19, 2025

An Oncogenic Hepatocyte-Induced Orthotopic Mouse Model of Hepatocellular Cancer Arising in the Setting of Hepatic Inflammation and Fibrosis
06:38

An Oncogenic Hepatocyte-Induced Orthotopic Mouse Model of Hepatocellular Cancer Arising in the Setting of Hepatic Inflammation and Fibrosis

Published on: September 12, 2019

9.2K

Immunotherapy in cholangiocarcinoma.

Raed Al-Rajabi1, Weijing Sun

  • 1The University of Kansas Medical Center, Department of Internal Medicine, Division of Medical Oncology, Westwood, Kansas, USA.

Current Opinion in Gastroenterology
|January 28, 2021
PubMed
Summary

Immunotherapy shows promise for treating cholangiocarcinoma, a biliary cancer. Advances in immune oncology may improve outcomes for patients with advanced disease by harnessing the immune system to fight cancer.

More Related Videos

Advances in Human Induced Pluripotent Stem Cell-Derived Chimeric Antigen Receptor-Expressing Natural Killer Cells
11:08

Advances in Human Induced Pluripotent Stem Cell-Derived Chimeric Antigen Receptor-Expressing Natural Killer Cells

Published on: February 14, 2025

1.4K
Induction of Invasive Transitional Cell Bladder Carcinoma in Immune Intact Human MUC1 Transgenic Mice: A Model for Immunotherapy Development
11:02

Induction of Invasive Transitional Cell Bladder Carcinoma in Immune Intact Human MUC1 Transgenic Mice: A Model for Immunotherapy Development

Published on: October 30, 2013

21.5K

Related Experiment Videos

Last Updated: Nov 19, 2025

An Oncogenic Hepatocyte-Induced Orthotopic Mouse Model of Hepatocellular Cancer Arising in the Setting of Hepatic Inflammation and Fibrosis
06:38

An Oncogenic Hepatocyte-Induced Orthotopic Mouse Model of Hepatocellular Cancer Arising in the Setting of Hepatic Inflammation and Fibrosis

Published on: September 12, 2019

9.2K
Advances in Human Induced Pluripotent Stem Cell-Derived Chimeric Antigen Receptor-Expressing Natural Killer Cells
11:08

Advances in Human Induced Pluripotent Stem Cell-Derived Chimeric Antigen Receptor-Expressing Natural Killer Cells

Published on: February 14, 2025

1.4K
Induction of Invasive Transitional Cell Bladder Carcinoma in Immune Intact Human MUC1 Transgenic Mice: A Model for Immunotherapy Development
11:02

Induction of Invasive Transitional Cell Bladder Carcinoma in Immune Intact Human MUC1 Transgenic Mice: A Model for Immunotherapy Development

Published on: October 30, 2013

21.5K

Area of Science:

  • Oncology
  • Immunology
  • Gastroenterology

Background:

  • Cholangiocarcinoma (CCA) is an aggressive biliary cancer with limited treatment options.
  • Most patients present with advanced metastatic disease, leading to a poor prognosis.
  • Current standard systemic therapy relies on cytotoxic chemotherapy.

Purpose of the Study:

  • To review the latest evidence on immunotherapy for cholangiocarcinoma treatment.
  • To explore the potential of immunotherapies in managing this aggressive cancer.
  • To highlight the promise of immune oncology in improving clinical outcomes.

Main Methods:

  • Review of recent scientific literature on immunotherapy and cholangiocarcinoma.
  • Analysis of genomic sequencing data identifying potential immunotherapeutic targets.
  • Evaluation of immune checkpoint inhibitors and cancer vaccines in preclinical and clinical studies.

Main Results:

  • Subgroups of cholangiocarcinoma with high mutation rates may respond to immunotherapy.
  • Cancer neoantigen production can elicit a host immune response against tumors.
  • Immunotherapies show potential in overcoming the immunosuppressive tumor microenvironment.

Conclusions:

  • Immunotherapy is an emerging and promising treatment modality for cholangiocarcinoma.
  • While still in early development, immunotherapy may improve response rates and durable disease control.
  • Further research is needed to optimize immunotherapy strategies for cholangiocarcinoma patients.